Thursday, October 08, 2015 7:05:42 AM
The new slides were excellent and the percentage of HU should have anyone that understands its importance related to our endpoints very excited. I was disappointed at the AIR001 portion of the presentation. After listing it in prominent manner on the PR I expected much more detailed information. As always stated the AIR001 will be a huge driver for the PPS. To remain positive the P2a data is still out there for us in Q4 along with the P2 trial initiation in CHF this month.
Hopeful for a delayed POSITIVE response to yesterday's presentation. There was alot of new EPIC information to digest and analysts need to absorb it and hopeful produce new forward looking thoughts to put out publicly for their clientele.
Have a great day everyone...RR
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM